Healthcare Social Media and Updates

Akeso’s ASCO Plenary Raises Questions on Lung Cancer Data
SocialApr 30, 2026

Akeso’s ASCO Plenary Raises Questions on Lung Cancer Data

This week's Biotech Scorecard: An #ASCO26 mystery: What does Akeso’s primo plenary spot say about its ivonescimab lung cancer survival data? $SMMT If the news was good, we'd have heard by now, right? Or, is Akeso just being ultra conservative?...

By Adam Feuerstein
Top 50 Digital Health Trends Shaping Patient‑Centric Future
SocialApr 30, 2026

Top 50 Digital Health Trends Shaping Patient‑Centric Future

The Technology Adoption Curve Of The Top 50 Emerging Digital Health Trends https://t.co/W9Cu2oIahi Explore a future where healthcare becomes seamless, preventive, and fully centered on you. In this concise analysis from The Medical Futurist, discover the digital technologies with real power...

By Bertalan Meskó, PhD
Sevabertinib Shows
SocialApr 30, 2026

Sevabertinib Shows

EGFR’s Poor Sibling {Editorial} [April 15, 2026] @DCarboneMD @NEJM https://t.co/DjV4gAtKMk #lcsm #PrecisionMedicine RE: #NCT05099172 Sevabertinib in Advanced HER2-Mutant Non–Small-Cell Lung Cancer https://t.co/63kCdZ6JOJ

By Mike Thompson, MD PhD
FDA Slowdown Threatens AZN's SERD Lead as Roche Advances
SocialApr 30, 2026

FDA Slowdown Threatens AZN's SERD Lead as Roche Advances

FDA just pumped the brakes hard on AZN's camizestrant. While the SERD track is crowded and Roche is picking up speed, AZN's innovation may be derailed by regulatory conservatism: https://t.co/9eroTXv5dc https://t.co/rOJwh9iMCz

By Sally Church
Trump's Second Term Eviscerated the CDC
SocialApr 30, 2026

Trump's Second Term Eviscerated the CDC

Gotta update my tweet again. What was cut from the CDC in the first Trump was but a flesh wound. What happened in Trump’s second term is complete evisceration.

By Angela Rasmussen
Biotech Liquidation Opportunities: ENDI, FNCH, LQDA Outlook
SocialApr 30, 2026

Biotech Liquidation Opportunities: ENDI, FNCH, LQDA Outlook

Please find Arquitos Capital's Q1 2026 letter below. I discuss opportunities in liquidating biotechs, $ENDI $FNCH and the range of potential outcomes for $LQDA. https://t.co/LJCczZ04W6

By Steven Kiel
Health Care Money Splits Parties, Still Blocks Colorado Public Option
SocialApr 30, 2026

Health Care Money Splits Parties, Still Blocks Colorado Public Option

The health care industry gives roughly the same amount of money to Democrats and Republicans We couldn’t even get a true public option in Colorado

By Rhet Lage (public health advocate)
Covid Vaccine Rollout Keeps Getting Delayed, Like Trump's Plan
SocialApr 30, 2026

Covid Vaccine Rollout Keeps Getting Delayed, Like Trump's Plan

the schedule for when the covid vaccine time bomb is finally going to go off keeps getting pushed back like trump's healthcare plan lmao

By Al Shipley
Australia’s Plasma Shortage Threatens Health and Costs
SocialApr 30, 2026

Australia’s Plasma Shortage Threatens Health and Costs

Could plasma be the new climate change? My column on how Australia's dwindling blood - and plasma - stocks are becoming an expensive problem. Perhaps the answer lies in the office if the right incentives are offered: https://t.co/m966D8rei1 (plus #Metallica...

By Nic Fildes
Midol Label Warns About Prostate Issues for Men
SocialApr 30, 2026

Midol Label Warns About Prostate Issues for Men

I’ve always wondered who wrote the label for Midol Complete (indicated for relief of menstrual symptoms). Because it says “ask a doctor before use if you have difficulty in urination due to enlargement of the prostate gland.” (Read that...

By Melissa Groves Azzaro, RDN
Balancing Care: Saving Others as Her Own Breath Fades
SocialApr 30, 2026

Balancing Care: Saving Others as Her Own Breath Fades

She was learning to keep others breathing while losing her own air [PODCAST] http://dlvr.it/TSHrbF Podcast #Pulmonology

By Kevin Pho, MD (KevinMD)
Calcium Supplements Linked to Higher Cardiovascular Event Recurrence
SocialApr 30, 2026

Calcium Supplements Linked to Higher Cardiovascular Event Recurrence

Association Between Calcium Supplementation and Recurrence of Cardiovascular Events in Patients With Cardiovascular Disease: A Population‐Based Cohort Study 👉 “Caution should be exercised” https://t.co/ynmqMB4Zd0

By David Barzilai, MD PhD
Exercise Proven to Reduce Biological (Epigenetic) Age
SocialApr 30, 2026

Exercise Proven to Reduce Biological (Epigenetic) Age

What is the most established intervention linked to lower biological (epigenetic) age? Exercise A new systematic review @LancetLongevity of 44 studies, >145,000 participants https://t.co/agmAazwDxs

By Eric Topol
Art and Recovery Cards Unite Colorado for Healing
SocialApr 30, 2026

Art and Recovery Cards Unite Colorado for Healing

Honored to join the Behavioral Health Administration’s 150/250 celebration at the Denver Public Library. Art connects and heals—proud to see the Recovery Cards Project support Coloradans on their path to recovery. A healthy Colorado means access to care for all.

By Governor Jared Polis
Gene Editing Swaps Whole Genes, Fixes 1,000 Mutations
SocialApr 30, 2026

Gene Editing Swaps Whole Genes, Fixes 1,000 Mutations

A new genome editing technique enables efficient replacement of entire genes, allowing correction of up to 1,000 mutations simultaneously by inserting large DNA segments without causing toxic double-strand breaks. genetherapy

By Phys.org Threads
Vaccines May Reduce Alzheimer Risk and Slow Aging
SocialApr 29, 2026

Vaccines May Reduce Alzheimer Risk and Slow Aging

I'm getting two vaccines next week: Tdap and shingles. The Tdap because Kate's family has a newborn and we're visiting. Shingles for the potential longevity benefits. Data we're looking at: 1. Lower Alzheimer risk with vaccination in 1.6 million people,...

By Bryan Johnson
AI Flags Low‑GC Flu Strains, Warning of Pandemic Risk
SocialApr 29, 2026

AI Flags Low‑GC Flu Strains, Warning of Pandemic Risk

A new AI classifier analyzes influenza A virus genomes to identify strains with reduced GC content, signaling a higher risk of sustained mammalian transmission and supporting earlier detection of potential pandemic threats. publichealth

By Phys.org Threads
Peer Review Immunity Leaves Vulnerable Doctors Unprotected
SocialApr 29, 2026

Peer Review Immunity Leaves Vulnerable Doctors Unprotected

You can buy malpractice insurance against a patient who thinks you harmed them. There is no insurance product, anywhere, that covers a physician against a peer who decides you are in the way. Up to 10 percent of peer reviews...

By Kevin Pho, MD
Licensure, Ethics, Not Coaching: Protect Black Mental Health
SocialApr 29, 2026

Licensure, Ethics, Not Coaching: Protect Black Mental Health

In this video, I break down a clip from the @thejoebuddenpod featuring @_drbryant and explain why her messaging about licensure, ethics, and mental health care is harmful, especially to the Black community she claims to serve. A doctorate tells you...

By Dr. Raquel Martin
Exercise Boosts Psychedelic Therapy’s Antidepressant Effects
SocialApr 29, 2026

Exercise Boosts Psychedelic Therapy’s Antidepressant Effects

The combination of exercise and psychedelics for the treatment of major depressive disorder "Through the lens of psychological and behaviour change, psychedelics appear to facilitate the adoption or maintenance of physical activity habits, increase psychological flexibility, and since exercise is associated...

By David Barzilai, MD PhD
Hospitals Must Serve Real Food or Lose Funding
SocialApr 29, 2026

Hospitals Must Serve Real Food or Lose Funding

This is one of the biggest MAHA wins to date and it deserves a moment of attention, because hospitals are finally being told to align their patient meals with actual dietary guidelines or risk losing Medicare and Medicaid funding. That...

By Dave Asprey
FDA Proposes AI-Driven Real-Time Trials, Ending Phase Gaps
SocialApr 29, 2026

FDA Proposes AI-Driven Real-Time Trials, Ending Phase Gaps

No more Phase 1, 2, or 3 in clinical trials? The FDA is proposing using AI to get trial data in real-time from EHRs and giving trial design feedback based on what it sees. No more batch processing could eliminate the wait...

By Seth Bannon
2C‑B Shows Dose‑Dependent Effects Similar to MDMA and Psilocybin
SocialApr 29, 2026

2C‑B Shows Dose‑Dependent Effects Similar to MDMA and Psilocybin

Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants https://t.co/OEJPk0XTqg

By Julie Holland
Every Day Brings Unpredictable Moments in Hospice Social Work
SocialApr 29, 2026

Every Day Brings Unpredictable Moments in Hospice Social Work

The role of a hospice social worker is different every single day. So far this week: Monday: I met a patient who believes the earth is flat. (Before you ask, no brain cancer or mets, just some unique ideas.) Tuesday: I met...

By Lisa Howe, MSW (Becoming Peaceful)
Small Stem Cell Edit Generates Persistent Antibody Protection
SocialApr 29, 2026

Small Stem Cell Edit Generates Persistent Antibody Protection

Researchers showed that editing a small number of blood stem cells can reprogram the immune system to continuously produce therapeutic proteins, including powerful antibodies that are normally hard to generate. In mice, this approach created long-lasting, boostable protection against infections...

By Liz Parrish
Official Style Guide Resolves Long‑Debated Health Writing Detail
SocialApr 29, 2026

Official Style Guide Resolves Long‑Debated Health Writing Detail

After YEARS of debate… It’s official- You know that one tiny detail you always second-guess when writing? Yeah… there’s finally an answer. Somewhere, every health journalist just breathed a sigh of relief 😅 Next up: payer vs payor… see you in 2035. #healthcare #payer...

By Christina Farr
Semaglutide Restores Lacrimal Gland, Relieves Age‑Related Dry Eye
SocialApr 29, 2026

Semaglutide Restores Lacrimal Gland, Relieves Age‑Related Dry Eye

Semaglutide alleviates age-related dry eye disease by restoring lacrimal gland structure and function https://t.co/EDvPtdeiqg https://t.co/Kpku8SHEOH

By David Barzilai, MD PhD
Future Pandemics and Cures May Begin in Basements
SocialApr 29, 2026

Future Pandemics and Cures May Begin in Basements

The next global pandemic will start in someone's basement. So will the vaccine for it. https://t.co/G3PVXy9eoY

By Dror Poleg
Reimagining Healthcare Infrastructure and Identity at SI Conference
SocialApr 29, 2026

Reimagining Healthcare Infrastructure and Identity at SI Conference

At SI annual conference learning from Laura Adams, RN on reimagining healthcare infrastructure and identity. Excellent talk. Appreciate the partnership Epic has with @theNAMedicine and @ScottsdaleInst. @HeyEpic @sethHain @wiley_ladd https://t.co/SDtb4DHak0

By Jackie Gerhart, MD
Unearthing Hidden Insights: Medicine’s Buried Knowledge
SocialApr 29, 2026

Unearthing Hidden Insights: Medicine’s Buried Knowledge

The burial and the excavation @JAMA_current commentary today https://t.co/PlzeKcj8Mq (what I wrote about in Deep Medicine, 2019) https://t.co/IehnDYXjzn

By Eric Topol
Polygenic Scores Predict Cardiovascular Risk, but Remain Unused Clinically
SocialApr 29, 2026

Polygenic Scores Predict Cardiovascular Risk, but Remain Unused Clinically

Polygenic risk scores for 8 cardiovascular traits in both @MassGenBrigham and @AllofUsResearch—superimposable— strongly indicate risk. Yet still not implemented in clinical practice https://t.co/DwWpwXknbJ

By Eric Topol
Teva Spends $700M on Tourette Drug, Shares Jump 11%
SocialApr 29, 2026

Teva Spends $700M on Tourette Drug, Shares Jump 11%

Teva nabs experimental Tourette drug in $700M Emalex buyout https://t.co/z1byYRgYul by @realJacobBell $TEVA + 11%

By Ben Fidler
Octant Bio Showcases Research at ARVO Conference
SocialApr 29, 2026

Octant Bio Showcases Research at ARVO Conference

Lots of folks from @OctantBio at ARVO this year. Come check out some of the talks/posters. https://t.co/UtY4mGuXAb

By Sri Kosuri
Late‑Stage Drug Development Trends: Phase III, AI, Global Partnerships
SocialApr 29, 2026

Late‑Stage Drug Development Trends: Phase III, AI, Global Partnerships

LOOKING forward to tomorrow's webinar on late-stage drug development trends with Susan Galbraith (AstraZeneca), Levi Garraway (Roche) and Ken Getz (Tufts). We'll be discussing the fundamentals of Phase III, with thoughts on efficiencies, interplay with biotech partners, China, AI, and...

By John Carroll
FDA Pilots Real-Time Trials as AbbVie Eyes KRAS Biotech
SocialApr 29, 2026

FDA Pilots Real-Time Trials as AbbVie Eyes KRAS Biotech

FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech https://t.co/diuieVTJ3g $ABBV $LLY $GSK $IONS $PFE #biotech

By Ben Fidler
Chiesi Acquires KalVista for $1.9B Rare Disease Drug
SocialApr 29, 2026

Chiesi Acquires KalVista for $1.9B Rare Disease Drug

Chiesi to buy KalVista in $1.9B deal for rare disease drug https://t.co/VR9hDYGLGJ by Kristin Jensen $KALV $PHVS $NTLA $BCRX $IONS

By Ben Fidler
FDA to Relax Peptide Rules After High‑profile Endorsement
SocialApr 29, 2026

FDA to Relax Peptide Rules After High‑profile Endorsement

FDA moves toward easing restrictions on certain peptides The agency’s decision to hold an advisory committee meeting on the topic comes after HHS Secretary Robert F. Kennedy Jr. told podcaster Joe Rogan he’s a “big fan” of peptides. https://t.co/wynhLuBUPE https://t.co/y9dgG0xWAq

By David Barzilai, MD PhD
Quintuple Receptor Agonist Outperforms Tirzepatide in Trials
SocialApr 29, 2026

Quintuple Receptor Agonist Outperforms Tirzepatide in Trials

New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case you thought a dual receptor was max effect, as...

By Eric Topol
Tomorrow's Dual AZN ODAC: Serena-6 AM, Truqap-281
SocialApr 29, 2026

Tomorrow's Dual AZN ODAC: Serena-6 AM, Truqap-281

Reminder that the dual $AZN ODAC takes place tomorrow. Camizestrant Serena-6 trial being debated in the morning, then Truqap Capitello-281 in the afternoon. Youtube link -> https://t.co/RDcvhRqVWR

By Jacob Plieth
Skin Nerve Fibers Slow Melanoma Growth, Challenging Cancer Neuroscience
SocialApr 29, 2026

Skin Nerve Fibers Slow Melanoma Growth, Challenging Cancer Neuroscience

A twist in cancer neuroscience with many studies showing hijacking of neurons to promote cancer—melanoma growth slowed by nerve fibers in skin https://t.co/9OWEAhJPOb https://t.co/XGSdYYPqk8

By Eric Topol
LFCR Undervalued; Upcoming Site Transfers Could Drive 25% Margins
SocialApr 29, 2026

LFCR Undervalued; Upcoming Site Transfers Could Drive 25% Margins

$LFCR beaten down again on fears of equity issuance, lingering preferred concerns, and general liquidity worries. They have enough liquidity to cover the preferreds. Debt is not a concern as of yet. Meanwhile, the company has reported 5 site transfers in the...

By Dalius – Special Sits
SYRE Jumps to $8B After Breakthrough UC Trial
SocialApr 29, 2026

SYRE Jumps to $8B After Breakthrough UC Trial

$SYRE pushing $8 billion cap currently on a major $XBI red day following their open label a4b7 data proving that a4b7 continues to work. Valuation was ~$3B at the start of the year. Must’ve been a massive surprise that their...

By Adam May
Health Care Ranks Equal to Gas in Voter Concerns
SocialApr 29, 2026

Health Care Ranks Equal to Gas in Voter Concerns

Even as gas prices cause real pain for consumers and dominate the news, our new poll finds health care tied with gas as the public's top economic worries. Health care affordability is a big issue for voters this year. https://www.kff.org/public-opinion/kff-health-tracking-poll-health-care-costs-and-the-midterms/

By Larry Levitt
Sleep: The Next Frontier in Health Innovation
SocialApr 29, 2026

Sleep: The Next Frontier in Health Innovation

We often think of medical interventions as being only about new breakthrough drugs or diagnostics, but our daily behaviors also have a profound impact on health outcomes. And it’s great to see that being increasingly recognized in the healthcare system....

By Arianna Huffington
Muse Headband’s Decade‑Long Evolution Boosts Mindfulness Guidance
SocialApr 29, 2026

Muse Headband’s Decade‑Long Evolution Boosts Mindfulness Guidance

About a decade ago, I had a chance to test the first Muse Headband that claimed to measure EEG (essentially brain waves) at home and provide biofeedback while doing meditations. Muse redesigned its device by 2026 and they sent me a...

By Bertalan Meskó, PhD
Egg Freezing: Expensive Gamble, Rarely Yielded Returns
SocialApr 29, 2026

Egg Freezing: Expensive Gamble, Rarely Yielded Returns

Egg freezing costs $10,000 to $20,000 per cycle. Most women need more than one cycle to bank enough eggs. Then you pay $500 to $1,000 a year in storage fees, indefinitely. According to the largest U.S. study to date, only...

By Preethi Kasireddy
Hospitals Wield Outsized Congressional Influence over Health Policy
SocialApr 29, 2026

Hospitals Wield Outsized Congressional Influence over Health Policy

in my 40 years covering Congress, hospitals have ALWAYS had disproportionate clout compared to other major players in the health care system.

By Julie Rovner
Democrats Shy Away From Hospital Criticism Amid Lobby Power
SocialApr 29, 2026

Democrats Shy Away From Hospital Criticism Amid Lobby Power

Yesterday's House committee hearing on health care affordability showed in stark terms how averse Democrats are to criticizing #hospitals, a testament to their lobbying power. https://t.co/3P1OKFc3rU via @statnews

By Tara Bannow
AI Cheapens Scans, Boosts Radiologist Demand and Salaries
SocialApr 29, 2026

AI Cheapens Scans, Boosts Radiologist Demand and Salaries

The Radiologist Paradox "A decade ago, AI was supposed to replace radiologists. Today, radiologists make more than $500,000 per year, and their employment continues to grow, see chart below. Reading scans is a task, not a job, and when the...

By Bijan Salehizedah